Recent publications


List of VHPB publications online available

A hepatitis-free future: strategy first, then pricing.
Heidi Larson, Pierre Van Damme & David FitzSimons
Lancet Infect Dis & 2016, 16(4):399-400. doi: 10.1016/S1473-3099(16)00126-2.
Editorial on “What is a potentially damaging vaccination delay in children younger than 2 years?”
Mark A. Kane, Francois Roudot-Thoraval, Nicole Guerin, Vassiliki Papaevangelou, Pierre Van Damme & on behalf of the Viral Hepatitis Prevention Board
Human Vaccines & Immunotherapeutics 2016, DOI:10.1080/21645515.2016.1177689

Recent newsletters


VHPB Newsletter

Prevention and control of viral hepatitis in the Baltic States: lessons learnt and the way forward
Newsletter 2/2016 - June/2016  Riga, Latvia 463 kB (.pdf)
Towards a hepatitis-free Europe: how to make it feasible and affordable
Newsletter 1/2016 - January/2016  London, United Kingdom 725 kB (.pdf)
Burden and prevention of viral hepatitis in Arctic region
Vol. 21.1 - Mar/2012  Copenhagen, Denmark 808 kB (.pdf)

News - European HIV-HEPATITIS Testing Week

Testing week is an initiative of HIV in Europe to help more people to become aware of their HIV status.

Now in its fourth year and the second time hepatitis testing has been included,

European HIV-Hepatitis Testing Week will take place from 18-25 November 2016.


News - EASL Recommendations on Treatment of hepatitis C 2016

The European Association for the Study of the Liver (EASL) issues Recommendations on Treatment of Hepatitits C 2016:

The recommendations have been prepared by a panel of experts chosen by the EASL Governing Board and were approved by the EASL Governing Board.
They have been based as far as possible on evidence from existing publications and presentations at international meetings, and, if evidence was unavailable, the experts’ personal experiences and opinion.


News - WHO E-learning course on Vaccine Safety Basics

The WHO e-learning course on vaccine safety basics intends to establish a shared understanding among professionals whose work is linked to vaccine safety issues.
The course addresses the following issues:

  • oringin and nature of advers events follwing immunzation; 
  • promoting good communication practices in handling risks and crises situations

The course is destined to nurses, midwives, community health workers, as well as pharmacists medical doctors and programme or technical officers.

More information:


News - European action plan on Viral Hepatitis adopted by the 66th Session of the WHO Regional Committee

At the Sixty-sixth Session of the WHO Regional Committee for Europe (RC66), the 53 Members States of the WHO European Region have unanimously adopted the first ever "Action plan for the health sector response to Viral Hepatitis in the WHO European Region”, and endorsed the resolution EUR/RC66/R10 to adopt the action plan:

Many Member States and WHO partners have voiced their support through strong statements of support at RC66.


News - International Viral Hepatitis Elimination Meeting 2016

The 3rd International Meeting on Elimination of Viral Hepatitis 2016 will be held from 2 - 3 December 2016 at the West Indisch Huis, Amsterdam, The Netherlands.

The field of viral hepatitis treatment is undergoing major changes and is on the verge of a paradigm shift. The introduction of Direct Acting Antivirals are providing great hopes for:

  • decreasing the burden of disease,
  • simplifying treatment and, ultimately,
  • the elimination of viral Hepatitis.

Older news items can be found in the news archive.